Test Price
2,800 AED✅ Home Collection Available
CHRND Gene Congenital Myasthenic Syndrome Type 3A (Slow Channel) Genetic Test in UAE – 2800 AED
Executive Summary & Core Metrics
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing.
Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily from 8 AM to 11 PM) for peripheral blood samples.
Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-licensed specialists for result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CHRND gene NGS test detects pathogenic variants causing Congenital Myasthenic Syndrome Type 3A (Slow Channel), confirming clinical suspicion and enabling targeted management. This comprehensive analysis uses next-generation sequencing to examine the entire coding sequence of CHRND, providing definitive molecular diagnosis for affected families in the UAE.
| Our Test | Closest Alternative |
|---|---|
| Precision: >99.9% analytical sensitivity & specificity (full CHRND NGS) | Sanger sequencing of selected exons – misses deep intronic/copy number variants |
| Methodology: NGS (Next Generation Sequencing) with Illumina platform, ACMG variant interpretation | Sanger sequencing or whole‑exome sequencing (broader but costlier, lower read depth per gene) |
| Speed: 3–4 Weeks | 4–8 weeks (exome), 2–3 weeks (Sanger) |
Physician Insight & Safety Protocols
“I understand the profound impact unexplained muscle weakness can have on daily life. This genetic test provides definitive evidence to distinguish congenital myasthenic syndrome type 3A from autoimmune myasthenia gravis or limb‑girdle muscular dystrophies, paving the way for accurate therapy and family planning. I emphasize that all results must be interpreted alongside your complete neurological examination and pedigree analysis.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory – Medication Continuation
Medication Warning
Do not discontinue any prescribed medication (e.g., pyridostigmine, salbutamol, or ephedrine) without explicit consultation with your treating neurologist. Abrupt cessation may precipitate severe respiratory crisis.
Exclusion Criteria & Emergency Red Flags
Patient Safety – Exclusion Criteria & Red Flags
- Exclusion: Active febrile illness or recent blood transfusion (within 2 weeks) may compromise DNA quality – inform the phlebotomist.
- Red Flag Symptoms: Sudden difficulty breathing, severe swallowing problems (choking), or new‑onset double vision with drooping eyelids – seek immediate emergency medical care; do not wait for test results.
- Age Restriction: Minors require consent from a legal guardian; the test is performed only after a genetic counselling session as mandated by UAE regulations.
Patient FAQ & Clinical Guidance
1. What is the CHRND gene slow channel congenital myasthenic syndrome test?
This NGS test sequences the entire CHRND gene to identify DNA variants responsible for congenital myasthenic syndrome type 3A, a disorder causing lifelong muscle weakness due to impaired neuromuscular transmission.
2. How is the sample collected and how long does it take?
A peripheral blood sample is collected at home by our DHA-licensed phlebotomist under cold-chain conditions, and results are delivered in 3–4 weeks via a secure online portal with optional clinician report review.
3. Can this be used for prenatal diagnosis or carrier testing?
Yes, after genetic counselling, the identified familial variant can be tested in chorionic villus sampling or amniocentesis; carrier testing for at-risk relatives is also available under UAE genetic data protection laws.
UAE Regulatory & Data Privacy Adherence
This genetic test fully complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data are encrypted and stored on HIPAA & ISO 27001 certified servers within the UAE. Our laboratory is ISO 9001:2015 certified (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CHRND Gene Congenital Myasthenic Syndrome Type 3A (Slow Channel) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (via VIP Mobile Phlebotomy) or FTA card |
| Methodology Used | NGS (Next Generation Sequencing) – Full coding region & splice sites of CHRND, ACMG variant interpretation |
| ICD-10-CM Code | G70.2 |
| LOINC Code | 94824-3 |
| DHA Facility License & Laboratory Address | Facility License Number: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians